BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

506365

CHEMOPH

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

CHEMO PHARMA LABORATORIES LTD. Share Price Update

As of the latest trading session, CHEMO PHARMA LABORATORIES LTD. share price is currently at ₹ 131.3, which is up by ₹ 0.00 from its previous closing. Today, the stock has fluctuated between ₹ 131.30 and ₹ 131.30. Over the past year, CHEMO PHARMA LABORATORIES LTD. has achieved a return of 55.20 %. In the last month alone, the return has been 3.30 %. Read More...

CHEMO PHARMA LABORATORIES LTD. fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    19.69

  • P/E Ratio (TTM)

    50.50

  • Beta

    0.63

  • Book Value / share

    91.06

  • Return on equity

    9.84%

  • EPS (TTM)

    2.60

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    -0.17

info icon alternate text

CHEMO PHARMA LABORATORIES LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.03
Net Profit -0.17
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -1.17
EBITDA -0.17
Effective Tax Rate (%) 0.00
Particulars SEP 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.02
Net Profit 0.61
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 4.07
EBITDA 0.61
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.06
Net Profit 0.25
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 1.64
EBITDA 0.25
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.10
Net Profit -0.29
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -1.94
EBITDA 0.15
Effective Tax Rate (%) 293.33
Particulars DEC 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.03
Net Profit 0.68
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 4.51
EBITDA 0.68
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.19
Net Profit 1.20
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 8.00
EBITDA 1.65
Effective Tax Rate (%) 26.82
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.22
Net Profit 0.05
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.32
EBITDA 0.08
Effective Tax Rate (%) 42.85
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.42
Net Profit 0.56
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 3.73
EBITDA 0.38
Effective Tax Rate (%) -55.55
Particulars MAR 2021 (Values in Cr)
Revenue 0.00
Operating Expense 0.36
Net Profit 0.25
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 1.67
EBITDA 0.33
Effective Tax Rate (%) 19.35
Particulars MAR 2020 (Values in Cr)
Revenue 0.00
Operating Expense 0.50
Net Profit 0.42
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 2.77
EBITDA 0.51
Effective Tax Rate (%) 16.32
Particulars MAR 2016 (Values in Cr)
Book Value / Share 24.49
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 85.35
ROE % 9.84
ROCE % 13.44
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 77.35
ROE % 0.43
ROCE % 0.78
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 77.03
ROE % 3.37
ROCE % 1.33
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share 73.30
ROE % 2.30
ROCE % 2.85
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2020 (Values in Cr)
Book Value / Share 71.63
ROE % 3.99
ROCE % 4.75
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2016 (Values in Cr)
Cash & Short Term Investments 0.43
Total Assets 3.86
Total Liabilities 3.86
Total Equity 3.67
Share Outstanding 1500000
Price to Book Ratio 0.50
Return on Assets (%) -37.44
Return on Capital (%) -39.44
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 6.10
Total Assets 13.01
Total Liabilities 13.01
Total Equity 12.80
Share Outstanding 1500000
Price to Book Ratio 0.76
Return on Assets (%) 9.22
Return on Capital (%) 9.38
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.05
Total Assets 11.62
Total Liabilities 11.62
Total Equity 11.60
Share Outstanding 1500000
Price to Book Ratio 0.52
Return on Assets (%) 0.40
Return on Capital (%) 0.41
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 6.18
Total Assets 11.66
Total Liabilities 11.66
Total Equity 11.55
Share Outstanding 1500000
Price to Book Ratio 0.54
Return on Assets (%) 4.80
Return on Capital (%) 4.85
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 10.87
Total Assets 11.05
Total Liabilities 11.05
Total Equity 10.99
Share Outstanding 1500000
Price to Book Ratio 0.24
Return on Assets (%) 2.26
Return on Capital (%) 2.27
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 8.80
Total Assets 10.96
Total Liabilities 10.96
Total Equity 10.74
Share Outstanding 1500000
Price to Book Ratio 0.09
Return on Assets (%) 3.78
Return on Capital (%) 3.86
Particulars MAR 2024 (Values in Cr)
Net Income 1.64
Cash from Operations 0.89
Cash from Investing -0.52
Cash from Financing -0.14
Net change in Cash 0.04
Free Cash Flow 0.89
Particulars MAR 2023 (Values in Cr)
Net Income 0.07
Cash from Operations -0.67
Cash from Investing 0.62
Cash from Financing -0.07
Net change in Cash -0.13
Free Cash Flow -0.67
Particulars MAR 2022 (Values in Cr)
Net Income 0.36
Cash from Operations -0.26
Cash from Investing 0.96
Cash from Financing -2.12
Net change in Cash -1.48
Free Cash Flow -0.26
Particulars MAR 2021 (Values in Cr)
Net Income 0.31
Cash from Operations -0.32
Cash from Investing -0.18
Cash from Financing 1.95
Net change in Cash 1.36
Free Cash Flow -0.32
Particulars MAR 2020 (Values in Cr)
Net Income 0.49
Cash from Operations 4.91
Cash from Investing 1.00
Cash from Financing 0.00
Net change in Cash 5.84
Free Cash Flow 4.91
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 37.10 19.95 2.02 284.31 34.11 / 77.70
BLISS GVS PHARMA LTD 122.65 16.07 1.27 1292.37 92.25 / 184.95
CIPLA LTD 1541.00 24.94 4.38 124457.39 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 272.25 22.56 2.76 801.26 145.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2904.45 57.61 29.41 49203.14 1924.30 / 3147.45
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 37.10 22.35 6.30 284.31 34.11 / 77.70
AMRUTAJAN HEALTH LTD 679.10 39.81 6.59 1963.32 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8795.90 131.18 32.36 21989.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 122.65 15.93 1.26 1292.37 92.25 / 184.95

CHEMO PHARMA LABORATORIES LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
131.30 0.00 redarrow
red-green-graph indicator
3 Bearish
13 Bullish
  • 5 Days 132.30
  • 26 Days 123.70
  • 10 Days 131.30
  • 50 Days 113.50
  • 12 Days 130.60
  • 100 Days 102.50
  • 20 Days 126.80
  • 200 Days 90.60
131.30 PIVOT

First Support

131.30

First Resistance

131.30

Second Support

131.30

Second Resistance

131.30

Third Support

131.30

Third Resistance

131.30

RSI

63.89

ADX

48.79

MACD

6.91

Williams % R

-31.67

Commodity Channel Index (CCI)

39.31

Date

2025-04-29

Week

572.00

Same Day

60.00

Month

2065.00

1 Year

0.64

3 Year

0.39

Over 1 Month

3.30%

down

Over 1 Year

55.20%

down

Over 3 Months

70.85%

down

Over 3 Years

46.27%

down

Over 6 Months

66.94%

down

Over 5 Years

84.21%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

CHEMO PHARMA LABORATORIES LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
71.74%
Promoter Holdings
27.88%
FII
0.0%
DII
0.36%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Citric India Ltd 369500.0 (24.63%) Shareholding of Promoter and Promoter Group
Shree Consultation And Services Pvt Ltd 54500.0 (3.63%) Public Shareholding
Shanta Somani 48781.0 (3.25%) Shareholding of Promoter and Promoter Group
Ravindra Somani 47411.0 (3.16%) Public Shareholding
Sudhir Harilal Kale 35000.0 (2.33%) Public Shareholding

News

Left Arrow
Right Arrow

CHEMO PHARMA LABORATORIES LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

CHEMO PHARMA LABORATORIES LTD. Share Price

Chemo Pharma Laboratories Limited was established in August, 1942 and has been making Pharmaceuticals and also had diversified into bulk drugs. However due to increase in competition and flow of new drugs, the Company had to dispose the business and pay all its liabilities and dues. Presently the Company has its own cash resource, with this the Company is proposing to diversify and to take over Sick Company which has excellent future potential. The Company is in advance in the negotiation to some other company and soon rehab to acquire business in Power and Chemicals.

Parent organization Indian Private
NSE symbol [-]
Founded 1942
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Chemo Pharma Laboratories Ltd?

Answer Field

The share price of Chemo Pharma Laboratories Ltd for NSE is ₹ 0.00 and for BSE is ₹ 131.30.

What is the Market Cap of Chemo Pharma Laboratories Ltd?

Answer Field

The market cap of Chemo Pharma Laboratories Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 19.70 Cr. as of now.

What is the 52 Week High and Low of Chemo Pharma Laboratories Ltd?

Answer Field

The 52 Week High and Low of Chemo Pharma Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 154.00 and ₹ 55.10.

How to Buy Chemo Pharma Laboratories Ltd share?

Answer Field

You can trade in Chemo Pharma Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Chemo Pharma Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 55.20%.

What is the Current Share Price of Chemo Pharma Laboratories Ltd?

Answer Field

Chemo Pharma Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 131.30 as on Apr 30 2025 10:15 AM.

What is the Market Cap of Chemo Pharma Laboratories Ltd Share?

Answer Field

The market cap of Chemo Pharma Laboratories Ltd for NSE ₹ 0.0 & for BSE ₹ 19.70 as on Apr 30 2025 10:15 AM.

What is the P/E Ratio of Chemo Pharma Laboratories Ltd Share?

Answer Field

As on Apr 30 2025 10:15 AM the price-to-earnings (PE) ratio for Chemo Pharma Laboratories Ltd share is 50.50.

What is the PB ratio of Chemo Pharma Laboratories Ltd Share?

Answer Field

As on Apr 30 2025 10:15 AM, the price-to-book (PB) ratio for Chemo Pharma Laboratories Ltd share is 91.06.

How to Buy Chemo Pharma Laboratories Ltd Share?

Answer Field

You can trade in Chemo Pharma Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Chemo Pharma Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Chemo Pharma Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Chemo Pharma Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|